LiveGMP
LiveGMP
The Grey Market Premium for this IPO is currently showing steady interest.
Cautious approach recommended for retail investors.
Details about NephroPlus (Nephrocare Health Services) are not yet available.
Investors looking at the NephroPlus (Nephrocare Health Services) IPO are closely monitoring the Grey Market Premium (GMP) to gauge potential listing gains. Being a Mainboard IPO, NephroPlus (Nephrocare Health Services) has attracted significant attention from both retail and institutional investors.
On this page, we provide real-time updates for NephroPlus (Nephrocare Health Services) GMP, live subscription status, and day-wise premium history. Our goal is to help you decide whether to apply for NephroPlus (Nephrocare Health Services) IPO based on fundamentals, market sentiment, and AI-powered analysis.
Track how many times NephroPlus (Nephrocare Health Services) is subscribed across Retail, HNI, and QIB categories. High subscription often leads to higher GMP and listing gains.
Based on the current GMP of NephroPlus (Nephrocare Health Services), calculate your potential profit per lot. Remember, GMP is indicative and the actual listing price may vary.
Always check the RHP (Red Herring Prospectus) of NephroPlus (Nephrocare Health Services) on the SEBI website for officially audited financials and risk factors before investing.
How to check NephroPlus (Nephrocare Health Services) IPO Allotment Status?
You can check the allotment status for NephroPlus (Nephrocare Health Services) on our Allotment Page once the registrar finalizes the basis of allotment.
What is the lot size for NephroPlus (Nephrocare Health Services)?
The lot size and price band for NephroPlus (Nephrocare Health Services) are available in the overview table above. Typically, one lot for a Mainboard IPO costs between ₹14,000 to ₹15,000 for retail investors.